Clinical Effect Exploration of Inhaled Acetylcysteine Solution Combined with Oseltamivir Phosphate in Treatment of Viral Pneumonia
Objective To explore clinical effect of inhaled acetylcysteine solution combined with oseltamivir phosphate in treatment of viral pneumonia.Methods The paper chose 86 patients with viral pneumonia in our hospital from January 2022 to December 2022,and divided them into two groups randomly.Control group was treated with oseltamivir phosphate only,while observation group with inhaled acetylcysteine solution.Clinical effect,symptom disappearance time,inflammatory factors,and T lymphocyte subsets were compared between two groups.Results Comparison of treatment effect showed observation group had higher and better curative effect(P<0.05).The disappearance time of symptoms and treatment time in observation group was significantly shorter than control group(P<0.05).After treatment,comparison of inflammatory indicators showed,CRP,PCT,LY,and IL-6 levels in observation group were lower,with greater decrease,(P<0.05).After treatment,the CD3+,CD4+,CD4+/CD8+levels in observation group were higher than control group,while CD8+levels were lower than control group(P<0.05).Conclusion Inhaling acetylcysteine solution combined with oseltamivir phosphate can achieve significantclinical effect in treatment of viral pneumonia,can inhibit inflammation,regulate immunity,and accelerate the speed of disease relief effectively.
Viral pneumoniaInhalation of acetylcysteine solutionOseltamivir phosphateClinical effect
NETL
NSTL
万方数据
